Antimicrobial-drug use and changes in resistance in Streptococcus pneumoniae.
about
Using hospital antibiogram data to assess regional pneumococcal resistance to antibioticsTelithromycin- and fluoroquinolone-resistant Streptococcus pneumoniae in Taiwan with high prevalence of resistance to macrolides and beta-lactams: SMART program 2001 data.Antimicrobial use and the emergence of antimicrobial resistance with Streptococcus pneumoniae in the United States.An analysis of why highly similar enzymes evolve differentlyRapidly increasing prevalence of penicillin-resistant Streptococcus pneumoniae in middle Tennessee: a 10-year clinical and molecular analysis.Linezolid and vancomycin, alone and in combination with rifampin, compared with moxifloxacin against a multidrug-resistant and a vancomycin-tolerant Streptococcus pneumoniae strain in an in vitro pharmacodynamic model.Impact of over-the-counter restrictions on antibiotic consumption in Brazil and Mexico.Limited spread of penicillin-nonsusceptible pneumococci, Skåne County, SwedenPopulation structure, epidemiology and antibiotic resistance patterns of Streptococcus pneumoniae serotype 5: prior to PCV-13 vaccine introduction in Eastern GambiaCommunity prescribing and resistant Streptococcus pneumoniae.Antibiotic use in Hispanic households, New York city.Risk factors for development of multiple-class resistance to Streptococcus pneumoniae Strains in Belgium over a 10-year period: antimicrobial consumption, population density, and geographic location.Availability of antibiotics without prescription in New York City.Geographic and temporal trends in antimicrobial nonsusceptibility in Streptococcus pneumoniae in the post-vaccine era in the United StatesEtiology issues and problems of antibiotic resistance.Antimicrobial peptides: their physicochemical properties and therapeutic application.Predicting the emergence of antimicrobial resistance.Linezolid, levofloxacin, and vancomycin against vancomycin-tolerant and fluoroquinolone-resistant Streptococcus pneumoniae in an in vitro pharmacodynamic model.Oxazolidinones: new players in the battle against multi-resistant Gram-positive bacteria.Antibiotic selection of multiply resistant pneumococci.
P2860
Q30772203-FAFE8B41-08D2-4CF3-9F3D-DA4A8FD89C16Q33187513-D9A8C721-C30A-4C06-B81A-5384D4AD8A2BQ34347889-D48C6E72-CF8E-440F-BC5E-023C628DA3B3Q34616960-C06D07A3-7B0E-4771-8FBC-0765F1FF62E5Q34946620-F8008233-CDC5-4903-9FE2-1770D6617DB7Q35013754-EFA3E24F-A333-47CF-8002-98A6AFDC3BBAQ35022423-458AEB00-803A-477F-98D6-802735FC792EQ35880428-5F7C27D8-1D84-4C6D-82A8-D195AB8A2B02Q35907857-84C29E8D-4B1F-45A7-9006-82B6FF0E86EFQ36009361-8EEABBE9-FA3E-4A04-8577-69777E5F25F5Q36088225-D07BEC02-6587-4E1C-AE7F-A9830B50DC01Q36095014-5A55E9EB-D25F-41F2-8CF2-E391E4E300C6Q36272407-005AF387-EA50-483B-BAB4-DA9637BAE142Q37187505-DE7EDB52-4CD6-4A5B-A40E-CEA088316A35Q37811605-94066E67-61DA-4CAF-A4AE-52FC4AFF89D7Q38000122-94BD8CBF-71E8-43AA-9DD7-47653F6E0CB4Q43974796-640518FD-A671-4EF8-947B-B5AAA063AE67Q44705813-B615AF5A-951E-40B7-BF72-2CDDDDD3EBDAQ46576587-47D7E410-47CA-44D6-886C-5B9BDBDE1604Q54001529-9A01CC1A-337D-47F6-B630-2F199B02B287
P2860
Antimicrobial-drug use and changes in resistance in Streptococcus pneumoniae.
description
2000 nî lūn-bûn
@nan
2000 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Antimicrobial-drug use and changes in resistance in Streptococcus pneumoniae.
@ast
Antimicrobial-drug use and changes in resistance in Streptococcus pneumoniae.
@en
type
label
Antimicrobial-drug use and changes in resistance in Streptococcus pneumoniae.
@ast
Antimicrobial-drug use and changes in resistance in Streptococcus pneumoniae.
@en
prefLabel
Antimicrobial-drug use and changes in resistance in Streptococcus pneumoniae.
@ast
Antimicrobial-drug use and changes in resistance in Streptococcus pneumoniae.
@en
P2093
P2860
P356
P1476
Antimicrobial-drug use and changes in resistance in Streptococcus pneumoniae.
@en
P2093
Brueggemann AB
Diekema DJ
P2860
P304
P356
10.3201/EID0605.000519
P577
2000-09-01T00:00:00Z